RE: Placing22 Feb 2024 18:49
I missed this bit from the RNS when I read it earlier
“The net proceeds will be used further the development of oral gallium maltolate, the oral anti-tumour agent currently under study in the phase 1 trial, via an intermediate-sized expanded access program and other commercialization initiatives necessary to fully leverage the Fast Track Designation granted by the US FDA.”
So if you add this to the Musella money that should help get the real world data and hopefully expedite the trial.
After all the negativity recently just looking for some positive news moving forward as most of us seem to be of the opinion we will continue to hold regardless of the frustration and anger we are all feeling at the moment.
I keep seeing people saying the PRD has been resubmitted, has that been confirmed and I have missed that as well?
Thanks